Articles published in Nuclear Medicine & Radiation Therapy have been cited by esteemed scholars and scientists all around the world.
Nuclear Medicine & Radiation Therapy has got h-index 12, which means every article in Nuclear Medicine & Radiation Therapy has got 12 average citations.
Following are the list of articles that have cited the articles published in Nuclear Medicine & Radiation Therapy.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|---|---|
Total published articles |
50 | 52 | 63 | 62 | 11 | 17 | 49 |
Research, Review articles and Editorials |
212 | 112 | 0 | 0 | 0 | 0 | 0 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
545 | 458 | 0 | 0 | 0 | 0 | 0 |
Conference proceedings |
0 | 0 | 0 | 0 | 0 | 0 | 22 |
Citations received as per Google Scholar, other indexing platforms and portals |
757 | 570 | 69 | 80 | 82 | 74 | 61 |
Journal total citations count | 706 |
Journal impact factor | 2.03 |
Journal 5 years impact factor | 1.8 |
Journal cite score | 1.98 |
Journal h-index | 12 |
Journal h-index since 2019 | 9 |
Arun Kumar, R., D. Sathish Kumar, and T. Nishanth. "A Confront on Cancer allied Diabetic Patients." J Carcinogene Mutagene 2, no. 126 (2011): 22-24. |
|
Hima Bindu, A. "A New Era of Liver Transplantation–Radioembolization, a Novel Therapy for Hepatocellular Carcinoma." J Cancer Sci Ther S 17 (2011): 2. |
|
Soumya, D. A. "Glimpse on melanoma-risk factors and treatment." J Cancer Sci Ther 3 (2011): 1-6. |
|
Sai, Y. R., A. Dattatreya, S. Y. Anand, and D. Mahalakshmi. "Biomark |
|
Sai, Y. R., A. Dattatreya, S. Y. Anand, and D. Mahalakshmi. "Biomark |
|
Nishant, T., H. K. Bindu, S. D. Kumar, and A. R. Kumar. "Pharmacogenomics-Personalized treatment of cancer, diabetes and cardiovascular diseases." J Pharmacogenom Pharmacoproteomics 3, no. 107 (2012): 2153-0645. |
|
Nishant, T., K. D. Sathish, K. R. Arun, B. K. Hima, and Y. Raviteja. "Bacteriocin producing probiotic lactic acid bacteria." J Microbial Biochem Technol 3 (2011): 5. |
|
Soumya, D., and R. Arun Kumar. "A brief assessment on cervical cancer." J Cancer Sci Ther S 17 (2011): 2. |
|
Nishant, T., H. K. Bindu, S. D. Kumar, and A. R. Kumar. "Pharmacogenomics-Personalized treatment of cancer, diabetes and cardiovascular diseases." J Pharmacogenom Pharmacoproteomics 3, no. 107 (2012): 2153-0645. |
|
Evolution of Quantification in Clinical Nuclear Medicine: A Brief Overview of Salient Uses and Upcoming Trends |
|
FMTVDM-Finally Opens the Doorway from Qualitative to Quantitative Measurement and Treatment of Heart Disease |
|
FMTVDM Study Proposal: WID2H - Breast Trial. (Weight, Inflammation, Diet v Drug, Heart disease) – Breast Trial |
|
Ordered subset expectation maximisation vs Bayesian penalised likelihood reconstruction algorithm in 18F-PSMA-1007 PET/CT |
|
NEMA NU 2–2007 performance characteristics of GE Signa integrated PET/MR for different PET isotopes |
|
Noise reduction using a Bayesian penalized-likelihood reconstruction algorithm on a time-of-flight PET-CT scanner |
|
Modern radiotherapy in the treatment of localized prostate cancer |
|
Megavoltage X-Ray Volumetric Modulated Arc Therapy and Multi-Entrance Three Dimensional Conformal Radiation Therapy for Prostate Cancer |
|
Evolution of Quantification in Clinical Nuclear Medicine: A Brief Overview of Salient Uses and Upcoming Trends |
|
Multi Center Clinical Trial Confirms FMTVDM©? MPI in Seven Modern Clinical Laboratories in the USA and Asia. Artificial Intelligence (AI) with True Quantification |
|
FMTVDM Study Proposal: WID2H - Breast Trial. (Weight, Inflammation, Diet v Drug, Heart disease) â?? Breast Trial |
|
Nuclear Medicine & Radiation Therapy received 706 citations as per Google Scholar report